PNPLA3 and diabetes mellitus: Conversely, a longitudinal study on 407 patients with diabetes and MASLD found a reduced risk of extrahepatic cancers in patients with PNPLA3 CG genotype respect to CC wild‐type, but not in GG homozygous [71].